v3.25.4

Accrued Liabilities and Other Liabilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Accrued Liabilities and Other Liabilities |
Summary of accrued liabilities and other liabilities | Accrued liabilities consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, | ​ | December 31,
(in thousands) | ​ ​ ​ | 2025 | ​ ​ ​ | 2024
Payroll and related benefits | ​ | $ | 851 | ​ | $ | 1,753
Clinical trial costs | ​ | ​ | 862 | ​ | ​ | 371
Sponsored research | ​ |  | 177 | ​ |  | 332
Lease liabilities, current portion | ​ | ​ | 1,005 | ​ | ​ | 796
License payments | ​ | ​ | 5,000 | ​ | ​ | —
Operating expenses | ​ | ​ | 525 | ​ | ​ | 845
Other | ​ |  | 135 | ​ |  | 124
Total accrued liabilities | ​ | $ | 8,555 | ​ | $ | 4,221
​

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration